APBI 2016

Prosigna (PAM50) (NanoString Technology, USA ) MOLECULAR SUBTYPES (LumA, LumB, HER2, Basal) FFPE SAMPLES 50 GENES LOCAL TEST (providing dedicated equipment and learning phase)

RECURRENCE (10 years) RISK OF RELAPSE (ROR) (node status needed)

LOW RISK + HT / NO CHEMOTHERAPY INTERMEDIATE HIGH RISK + HT / + CHEMOTHERAPY